Latest News
Yasoo Health Inc. Closes Series C Financing
August 18, 2008 - Yasoo Health Inc. (Yasoo) closes Series C Financing from Emergomed Limited. Yasoo plans to use this funding to further develop its pipeline of research based products consisting of essential nutrients and natural compounds to help overcome malabsorption and reduce oxidative stress in chronic diseases. Proceeds will also be used to strengthen the company’s sales and marketing capabilities for the upcoming introduction of Syndion™, a new antioxidant multivitamin and mineral supplement formulated for children and adults with special nutritional needs and food sensitivities.*
* This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease.